The ABUS system, which is currently the only approved method of ultrasound breast cancer screening in the world, is part of Preventica's high-tech equipment. Some of the advantages of this modern test include short examination time, operator independence and cancer detection sensitivity reaching almost 100%.
The country's only automated breast diagnostic ultrasound system clearly shows the individual breast anatomical structures. This distinguishes liquid from solid formations and can clearly differentiate malignant from benign lesions. Scientific research shows that the supplementary use of ABUS increases the chance of detecting breast cancer by 2-6 times.
According to statistics, newly detected carcinomas are in advanced stages three and four, which leads to expensive treatment and often a fatal outcome. Invenia ABUS detects tumor formations at a very early stage, which has a great impact on determining the course of the disease, therapy and follow-up. The advanced test is recommended for women over 40 as well as those with a family history of breast or ovarian cancer.
